1. Home
  2. ACOG vs APLT Comparison

ACOG vs APLT Comparison

Compare ACOG & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • APLT
  • Stock Information
  • Founded
  • ACOG 2000
  • APLT 2016
  • Country
  • ACOG Canada
  • APLT United States
  • Employees
  • ACOG N/A
  • APLT N/A
  • Industry
  • ACOG
  • APLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACOG
  • APLT Health Care
  • Exchange
  • ACOG Nasdaq
  • APLT Nasdaq
  • Market Cap
  • ACOG 91.6M
  • APLT 80.3M
  • IPO Year
  • ACOG N/A
  • APLT 2019
  • Fundamental
  • Price
  • ACOG $5.91
  • APLT $0.61
  • Analyst Decision
  • ACOG
  • APLT Buy
  • Analyst Count
  • ACOG 0
  • APLT 7
  • Target Price
  • ACOG N/A
  • APLT $6.10
  • AVG Volume (30 Days)
  • ACOG 137.9K
  • APLT 5.7M
  • Earning Date
  • ACOG 11-15-2024
  • APLT 03-05-2025
  • Dividend Yield
  • ACOG N/A
  • APLT N/A
  • EPS Growth
  • ACOG N/A
  • APLT N/A
  • EPS
  • ACOG N/A
  • APLT N/A
  • Revenue
  • ACOG N/A
  • APLT N/A
  • Revenue This Year
  • ACOG N/A
  • APLT N/A
  • Revenue Next Year
  • ACOG N/A
  • APLT $2,622.90
  • P/E Ratio
  • ACOG N/A
  • APLT N/A
  • Revenue Growth
  • ACOG N/A
  • APLT N/A
  • 52 Week Low
  • ACOG $4.66
  • APLT $0.55
  • 52 Week High
  • ACOG $7.00
  • APLT $10.62
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • APLT 26.91
  • Support Level
  • ACOG N/A
  • APLT $0.54
  • Resistance Level
  • ACOG N/A
  • APLT $0.63
  • Average True Range (ATR)
  • ACOG 0.00
  • APLT 0.07
  • MACD
  • ACOG 0.00
  • APLT 0.12
  • Stochastic Oscillator
  • ACOG 0.00
  • APLT 30.68

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a commercial-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI), for which there are currently no approved treatment options.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: